The Privatklinik Dr. Robert Schindlbeck brand, founded in 1946 (Germany), from 28 sister brands and 2617 competing brands. Privatklinik Dr. Robert Schindlbeck is owned by Myriad Genetics, listed on the stock exchange of New York Privatklinik Dr. Robert Schindlbeck belongs to the Medical Diagnostics & Research business sector.
Share price and profitability of the share Myriad Genetics (Privatklinik Dr. Robert Schindlbeck)
Buy Myriad Genetics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Myriad Genetics
(Privatklinik Dr. Robert Schindlbeck)
over 5 years*
USD 10.65
Stock market history Myriad Genetics (Privatklinik Dr. Robert Schindlbeck)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
